GlassScriptPhysician profile
Sunita B Jayakar
NPI 1982708608
$681.78
in general payments reported to CMS, 2019-2025
10 companies · $24.89 in 2025
The $24.89 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $16.66 · 2021: $134 · 2022: $153 · 2023: $180 · 2024: $28.08 · 2025: $24.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $181.93 | 2019-2022 | |
| Si-Bone, INC. | $150.34 | 2023 | |
| Electronic Waveform Lab, INC. | $136.19 | 2022-2023 | |
| Vertex Pharmaceuticals Incorporated | $52.97 | 2024-2025 | |
| Zyla Life Sciences, INC. | $47.53 | 2019 | |
| Assertio Therapeutics, INC. | $33.88 | 2019 | |
| Pfizer INC. | $22.88 | 2019 | |
| Bioventus LLC | $22.02 | 2022 | |
| Biodelivery Sciences International, INC. | $17.95 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunita Jayakar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.